On Wednesday (April 4), CannaRoyalty (CSE:CRZ,OTCQX:CNNRF) presented its financial results for Q4 2017, revealing a busy quarter of acquisitions in California.

CannaRoyalty acts as an investor of cannabis businesses in the available legal US market. As part of its quarterly report, the company revealed a revenue stream of C$1,072,399 was generated.

During its most recent quarter results, the company sought to acquire Alta Supply and River Distributions as a way to strengthen its distribution capabilities. CannaRoyalty also closed the acquisition of Kaya Management, the manufacturer of the “Bhang” vaporizer brand of products.

“We believe we are well positioned given our focus on the distribution side of things but creating an open and independent system,” Afzal Hasan, executive VP of corporate development said during a conference call.

CannaRoyalty determined it created C$3,077,969 worth of revenue for the entire business year, which split between four components: products, services, royalties, and interest. Royalties gathered the largest amount of revenue for CannaRoyalty, collecting C$1,103,645 during the year.

“Our market-leading distribution business places us in an ideal position to be a partner of choice for leading brands and dispensaries across the state,” CEO Marc Lusting said.

After the markets closed on Wednesday, the company’s Canadian stock rose 2.98 percent, reaching C$3.80 on the Canadian Securities Exchange (CSE). On Thursday (April 5) the company has continued its trend upwards, with a 0.26 percent increase after markets closed.

CannaRoyalty exploring possibility of taking its brands outside of the US market

Lusting highlighted one of the more intriguing propositions by the company so far this year is the potential to bring its brand into jurisdictions outside the US and starting with Canada.

When the announcement was originally made of CannaRoyalty’s intentions to possibly bring its brands to Canada, Hasan told the Investing News Network (INN) the company had to secure a pathway for the distribution of its product before the regulations explicitly say about it.

Hasan also told INN the way for CannaRoyalty to enter the Canadian market could come via a licensing deal where another company pays a fee to bring the specific brands into the market.

Another option is for CannaRoyalty to downright acquire its own licensed producer (LP) or obtain a facility to get an LP status. It’s unclear what Canadian regulators would do regarding CannaRoyalty’s stance, given that on a federal level marijuana remains illegal in the US.

“Right now we are focused on building a platform in California to foster the creation of the global cannabis consumer product brands of the future,” Hasan said during the call.

During the call Lusting said he is focused on five distinctive opportunities for CannaRoyalty in the cannabis space, including the integration of the company’s most recent acquisitions, continue its strategic acquisitions, set the fundamentals for the option to expand the reach of their brands into Canada and other jurisdictions, and a focus and rationalization of their portfolio.

During the question period of the call, Alan Brochstein, cannabis analyst with 420 Investor asked what the landscape was for more acquisitions in California.

Lusting answered by explaining there is a lot of opportunity for CannaRoyalty based on the fact that a lot of cannabis businesses remain unlicensed after the legalization of recreational cannabis this year.

“What that means is that there are a number of revenue streams in the market that did have a fair amount of that market share and consumer perception share as well that are up for sale right now,” he said.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less